US Broker Ratings

Bioventus Inc. (BVS) Stock Analysis: Exploring a 12% Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) stands out as a dynamic player in the healthcare sector, specifically within the medical devices industry. With a market capitalization nearing $893 million, this U.S.-based company..

Pharvaris N.V. (PHVS) Stock Analysis: A Biotech with 41.23% Potential Upside

Pharvaris N.V. (PHVS) stands as a promising player in the biotechnology sector, focusing on therapies for rare diseases with unmet medical needs. Headquartered in Zug, Switzerland, Pharvaris has carved a..

Arbutus Biopharma Corporation (ABUS)

⚠️ No article content returned.

..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Biotech Innovator with 80% Upside Potential

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with a promising pipeline targeting autoimmune diseases and cancer. With a market capitalization of $1.08..

Valneva SE (VALN) Stock Analysis: Assessing a Potential 139.86% Upside in Biotechnology

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in the development and commercialization of prophylactic vaccines, stands out in the healthcare sector with a compelling growth narrative. Despite recent..

Claritev Corporation (CTEV) Stock Analysis: Unveiling a 59.74% Potential Upside in Healthcare Analytics

Claritev Corporation (NASDAQ: CTEV), a pivotal player in the Healthcare Information Services industry, is making waves with its innovative solutions in data analytics and cost management. Headquartered in McLean, Virginia,..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a 192% Potential Upside in Genetic Therapy Innovations

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is garnering attention in the biotechnology sector with its promising ventures in genetic therapies for rare and devastating diseases. Based in Cranbury, New Jersey, this..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 227% Potential Upside in the Biotech Sector

Inventiva S.A. – American Depositary Shares (IVA) is making waves in the biotechnology sector with an impressive 227.15% potential upside, as indicated by the average target price of $15.11. This..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with 8.80% Revenue Growth in Focus

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, showcases a blend of promising growth and underlying challenges. With a market capitalization of..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unpacking the 57% Upside Potential and Analyst Consensus

Tyra Biosciences, Inc. (NASDAQ: TYRA) is currently capturing the attention of investors with its innovative approach in the biotechnology sector, focusing on precision medicines targeting fibroblast growth factor receptor (FGFR)..

Xencor, Inc. (XNCR) Investor Outlook: 31.84% Potential Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR) stands as a compelling player in the biotechnology sector, with a focus on pioneering antibody therapies to combat cancer and autoimmune diseases. As a clinical-stage biopharmaceutical..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Unpacking a 59.68% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL), a promising player in the healthcare sector, is making waves with its focus on molecular diagnostics for dermatologic cancers and other serious conditions. With a..

Orthofix Medical Inc. (OFIX) Stock Analysis: A Promising 31.47% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical devices industry, presents an intriguing investment opportunity for those interested in the healthcare sector. With a market capitalization of..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Potential 455% Upside in the Biotech Sector

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biotechnology sector, is capturing attention with its intriguing focus on vision improvement therapies. For investors looking at the healthcare landscape,..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Why Investors Eye a 48.97% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, specializes in the development and commercialization of innovative pain management solutions. With a market cap of $1.17 billion,..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating the Healthcare Tech Landscape with a Modest Growth Potential

For investors keen on the intersection of healthcare and technology, Simulations Plus, Inc. (NASDAQ: SLP) presents a unique proposition. Operating within the healthcare sector, specifically the health information services industry,..

Butterfly Network, Inc. (BFLY) Stock Analysis: Navigating a 25% Revenue Growth in the Healthcare Sector

Butterfly Network, Inc. (BFLY), a trailblazer in the healthcare sector, has been making waves with its innovative handheld ultrasound imaging solutions. As a player in the competitive medical devices industry,..

Arvinas, Inc. (ARVN) Stock Analysis: A Potential 78% Upside for Biotechnology Enthusiasts

Arvinas, Inc. (ARVN), a clinical-stage biotechnology innovator based in New Haven, Connecticut, is capturing the attention of investors with its pioneering approach to tackling disease-causing proteins through targeted protein degraders...

Definitive Healthcare Corp. (DH) Stock Analysis: A 206.79% Potential Upside Beckons Investors

Definitive Healthcare Corp. (NASDAQ: DH) stands at a compelling juncture for investors seeking to explore opportunities in the healthcare information services sector. With a current market cap of $75.67 million,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is at the forefront of developing innovative therapies for central nervous system (CNS) disorders. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds